ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
65,766.30
0.60%
S&P 500
5,399.22
-0.51%
Dow Jones
39,935.07
0.20%
US Dollar vs Yen
153.653
-0.16%
Brent Oil
81.535
0.99%
Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. USOTC
  6. Bionik Laboratories Corporation (CE) (BNKL)

  7. Bionik Laboratories Corporation (CE) (BNKL) ニュース

BNKL

Bionik Laboratories (CE) (BNKL)

Bionik Laboratories Corporation (CE)
から:
次の項目別のソート:
 Showing the most relevant articles for your search:USOTC:BNKL
日付受信時刻ニュースソース見出しコード企業名
2023/07/0105 : 31Edgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]USOTC:BNKLBionik Laboratories Corporation (CE)
2023/06/2206 : 05Edgar (US Regulatory)Annual Report (10-k)USOTC:BNKLBionik Laboratories Corporation (CE)
2023/06/2123 : 59Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:BNKLBionik Laboratories Corporation (CE)
2023/06/2123 : 58Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:BNKLBionik Laboratories Corporation (CE)
2023/06/2123 : 58Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:BNKLBionik Laboratories Corporation (CE)
2023/06/2123 : 56Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:BNKLBionik Laboratories Corporation (CE)
2023/06/1621 : 56Edgar (US Regulatory)Current Report Filing (8-k)USOTC:BNKLBionik Laboratories Corporation (CE)
2023/06/1602 : 10Edgar (US Regulatory)Current Report Filing (8-k)USOTC:BNKLBionik Laboratories Corporation (CE)
2023/05/0506 : 25Edgar (US Regulatory)Current Report Filing (8-k)USOTC:BNKLBionik Laboratories Corporation (CE)
2023/04/2705 : 31Edgar (US Regulatory)Current Report Filing (8-k)USOTC:BNKLBionik Laboratories Corporation (CE)
2023/02/2406 : 08Edgar (US Regulatory)Current Report Filing (8-k)USOTC:BNKLBionik Laboratories Corporation (CE)
2023/02/0906 : 21Edgar (US Regulatory)Current Report Filing (8-k)USOTC:BNKLBionik Laboratories Corporation (CE)
2023/02/0822 : 02Edgar (US Regulatory)Quarterly Report (10-q)USOTC:BNKLBionik Laboratories Corporation (CE)
2023/01/2106 : 32Edgar (US Regulatory)Current Report Filing (8-k)USOTC:BNKLBionik Laboratories Corporation (CE)
2022/12/0801 : 29Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)USOTC:BNKLBionik Laboratories Corporation (CE)
2022/12/0801 : 27Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)USOTC:BNKLBionik Laboratories Corporation (CE)
2022/11/1807 : 26Edgar (US Regulatory)Current Report Filing (8-k)USOTC:BNKLBionik Laboratories Corporation (CE)
2022/11/0922 : 01Edgar (US Regulatory)Quarterly Report (10-q)USOTC:BNKLBionik Laboratories Corporation (CE)
2022/11/0921 : 31Edgar (US Regulatory)Current Report Filing (8-k)USOTC:BNKLBionik Laboratories Corporation (CE)
2022/11/0722 : 02Edgar (US Regulatory)Current Report Filing (8-k)USOTC:BNKLBionik Laboratories Corporation (CE)
2022/11/0505 : 32Edgar (US Regulatory)Amended Current Report Filing (8-k/a)USOTC:BNKLBionik Laboratories Corporation (CE)
2022/10/2600 : 28Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:BNKLBionik Laboratories Corporation (CE)
2022/10/1402 : 18Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:BNKLBionik Laboratories Corporation (CE)
2022/10/1321 : 01Edgar (US Regulatory)Current Report Filing (8-k)USOTC:BNKLBionik Laboratories Corporation (CE)
2022/09/0820 : 32Edgar (US Regulatory)Current Report Filing (8-k)USOTC:BNKLBionik Laboratories Corporation (CE)
2022/09/0120 : 31Edgar (US Regulatory)Current Report Filing (8-k)USOTC:BNKLBionik Laboratories Corporation (CE)
2022/09/0105 : 31Edgar (US Regulatory)Current Report Filing (8-k)USOTC:BNKLBionik Laboratories Corporation (CE)
2022/08/1620 : 35Edgar (US Regulatory)Current Report Filing (8-k)USOTC:BNKLBionik Laboratories Corporation (CE)
2022/08/1021 : 03Edgar (US Regulatory)Quarterly Report (10-q)USOTC:BNKLBionik Laboratories Corporation (CE)
2022/08/1020 : 31Edgar (US Regulatory)Current Report Filing (8-k)USOTC:BNKLBionik Laboratories Corporation (CE)
 Showing the most relevant articles for your search:USOTC:BNKL

最近閲覧した銘柄

NASDAQ
NVDA
NVIDIA
NYSE
MCD
McDonalds
NYSE
DIS
Walt Disney
FX
USDGBP
US Dollar vs Sterling
AMEX
XLE
Energy Select Sector SPDR
USOTC
BASFY
BASF (QX)
NYSE
BAC
Bank of America
NYSE
MRK
Merck
USOTC
RHHBY
Roche (QX)
AMEX
SPY
SPDR S&P 500
NYSE
VZ
Verizon Communications
CCOM
US30
US 30
FX
USDEUR
US Dollar vs Euro
NASDAQ
AMZN
Amazon.com
USI
USTECH100
US Tech 100
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有